Internal Server Error

Flamma Group - About the company

Flamma Group is an unfunded company based in Bergamo (Italy), founded in 1950 by Gianpaolo Negrisoli, Edmea Kullmann and Marco Maria Negrisoli. It operates as a Manufacturer of pharmaceutical APIs. Flamma Group has not raised any funding yet. The company has 969 active competitors, including 38 funded and 137 that have exited. Its top competitors include companies like Laurus Labs, Symbiotec and NGL Fine Chem.

Company Details

Social
X
Key Metrics
Founded Year
1950
Location
Bergamo, Italy
Stage
Unfunded
Ranked
Employee Count
486 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Sign up to download Flamma Group's company profile

Flamma Group's funding and investors

Flamma Group has not raised any funding rounds yet.

Flamma Group's founders and board of directors

Founder? Claim Profile
The founders of Flamma Group are Gianpaolo Negrisoli, Edmea Kullmann and Marco Maria Negrisoli. Gianpaolo Negrisoli and Carlos Pereira are the CEOs of Flamma Group.
Here are the details of Flamma Group's key team members:

Flamma Group's employee count trend

Flamma Group has 486 employees as of Sep 26. Here is Flamma Group's employee count trend over the years:
Employee count trend for Flamma Group
lockUncover Flamma Group's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Flamma Group's Competitors and alternates

Top competitors of Flamma Group include Laurus Labs, Symbiotec and NGL Fine Chem. Here is the list of Top 10 competitors of Flamma Group, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Laurus Labs
Laurus Labs
2005, Hyderabad (India), Public
Pharmaceutical and biotechnology company
$230M
78/100
2nd
Logo for Symbiotec
Symbiotec
2002, Indore (India), Acquired
Manufacturer of non sterile steroid hormone based APIs and intermediates
$61.1M
64/100
3rd
Logo for NGL Fine Chem
NGL Fine Chem
1981, Mumbai (India), Public
CDMO specializing in multi stage organic synthesis of generic APIs and fine chemicals
-
-
59/100
4th
Logo for Neuland
Neuland
1984, Hyderabad (India), Public
Manufacturer of active pharmaceutical ingredients (APIs) and peptides
-
58/100
5th
Logo for Embio
Embio
1986, Mumbai (India), Late Stage
Contract research and manufacturing company engaged in APIs and chiral intermediates
$50.3M
58/100
6th
Logo for Snapdragon Chemistry
Snapdragon Chemistry
2014, Cambridge (United States), Acquired
CDMO providing API development, manufacturing, and analytical services
-
55/100
7th
Logo for SeQuent
SeQuent
2002, Bengaluru (India), Acquired
APIs Manufacturer
-
54/100
8th
Logo for ST PHARM
ST PHARM
2008, Siheung si (South Korea), Public
CDMO providing oligonucleotide, mRNA, and small molecule services
-
54/100
9th
Logo for Hikal
Hikal
1988, Mumbai (India), Public
Traditional company offering contract research, custom synthesis & custom manufacturing of APIs and intermediates
-
 
53/100
10th
Logo for Enaltec Labs
Enaltec Labs
2006, Mumbai (India), Acquired
Provider of complex small-volume technology-driven pharmaceutical products
$8.56M
53/100
87th
Logo for Flamma Group
Flamma Group
1950, Bergamo (Italy), Unfunded
Manufacturer of pharmaceutical APIs
-
-
38/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Flamma Group's competitors? Click here to see the top ones

Flamma Group's Investments and acquisitions

Flamma Group has acquired Lundbeck. Flamma Group has not made any investments as of now.

Reports related to Flamma Group

Here is the latest report on Flamma Group's sector:

News related to Flamma Group

Media has covered Flamma Group for a total of 2 events in the last 1 year.
•
Flamma USA Successfully Passes FDA InspectionContract Pharma•Feb 24, 2026•Flamma Group
•
Flama Names Giorgio Bertolini New GM in ItalyContract Pharma•Oct 24, 2024•Flamma Group
•
FLAMMA to Invest $200M Over the Next Three YearsContract Pharma•Mar 20, 2023•Flamma Group
•
FLAMMA Group Acquires Additional API Site in ItalyPharmaceutical Outsourcing•Mar 17, 2022•Flamma Group
•
FLAMMA USA Completes Commissioning of HPAPI SuiteContract Pharma•Nov 01, 2021•Flamma Group
•
Flamma, Gilead Continue Mfg. Partnership for VekluryContract Pharma•Nov 06, 2020•Flamma Group, Gilead
•
Flamma Breaks Ground for New R&D Facility in ItalyContract Pharma•Jun 03, 2020•Flamma Group
•
Flamma opens $20m cGMP facility in ChinaOutsourcing-Pharma•May 16, 2017•Flamma Group
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Flamma Group

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford